BioCryst Pharmaceuticals | BCRX - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
Alnylam Pharmaceuticals 2.23K 130 2024-12
BioCryst Pharmaceuticals 536 5 2023-12
Chugai Pharma 7.78K 174 2024-12
Daiichi Sankyo 19.76K 1.04K 2025-12
DBV Technologies USD 104 19 2023-12
Enanta Pharmaceuticals 145 15 2023-09
Gilead Sciences 17.6K 400 2024-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Glaxosmithkline GBP 69.4K 20.7K 2022-12
Incyte 2.62K 93 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Karyopharm Therapeutics 325 60 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Novavax 1.54K 449 2023-12
PTC Therapeutics 939 49 2024-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sarepta Therapeutics 1.37K 58 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vertex Pharmaceuticals 6.1K 700 2024-12